Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer

Recruiting now

Conditions studied: Gastric Cancer (GC), HIPEC, Peritoneal Metastases From Gastric Cancer, Hyperthermic Intraperitoneal Chemoperfusion

In brief

The study investigates the outcomes of hyperthermic intraperitoneal chemoperfusion (HIPEC) in combination with curative-intent gastrectomy in resectable locally-advanced and limited-metastatic (low peritoneal cancer index) gastric cancer.

Key facts

Study ID
NCT07313579
Run by
Ukrainian Society of Clinical Oncology
People needed
200
Starts
2025-12-01
Expected to finish
2035-12-01
Last updated by the study team
2026-01-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.